Alkan Pharma

Sorin Group Concludes Sale of Its Renal Care Business to Investment Consortium Led by Argos Soditic and MPS Venture SGR.(Company overview)
Business Wire; 12/30/2008; 1437 words; ...in Italy, and Maillefer (machinery), Axyntis (specialty pharma and chemicals) and ORS (services) in Switzerland. In 2006...two BIMBOs (Axyntis and Marie Laure PLV), one spin-off (Alkan) and two MBI (Chronolyss and Mertz). For more in

Sorin Group Announces Receipt of Offer for the Acquisition of Its Renal Care Business from Investment Consortium Led by Argos Soditic and MPS Venture SGR.
Business Wire; 10/9/2008; 1142 words; ...in Italy, and Maillefer (machinery), Axyntis (specialty pharma and chemicals) and ORS (services) in Switzerland. In 2006...two BIMBOs (Axyntis and Marie Laure PLV), one spin-off (Alkan) and two MBI (Chronolyss and Mertz). For further information...

Partnering in the Global Generics Industry 2008: A Guide to Companies.
M2 Presswire; 8/8/2008; 1152 words; ...controlling investments in 2007/08: - Target - Strides - TAD - AxiCorp GmbH - Medicamenta - Kyowa Pharmaceutical - Alkan Pharma - Hisyn Pharmaceutical - Buyer - Genepharm - Aurobindo - Biocon - Glenmark - Lupin Laboratories - Hikma - Hovione Teva...

Global values Hikma stock at GBP5.47 and maintains a 'BUY' on the stock.(Hikma Pharmaceuticals PLC)(Financial report)
Albawaba.com; 5/1/2008; 1426 words; ...businesses. The organic growth of the company (i.e. excluding the acquisitions of Ribosepharm, Thymoorgan and Alkan Pharma) was 28.0% during the year 2007. Revenue in the Branded Pharmaceuticals business increased by 52.9% to US...

Global values Hikma stock at GBP5.47 and maintains a 'BUY' on the stock
Al Bawaba; 5/1/2008; 1197 words; ...businesses. The organic growth of the company (i.e. excluding the acquisitions of Ribosepharm, Thymoorgan and Alkan Pharma) was 28.0% during the year 2007. Revenue in the Branded Pharmaceuticals business increased by 52.9% to US...